ESR1 and breast cancer: A recent study using the TCGA data identified nine regions of deletion that were unique to estrogen receptor positive (ER+) post menopause tumors in patients with breast cancer [45], including deletion in 7p22.3, where our newly-identified deletion in cases only was located, and it contains a known tumor suppressor gene.